News

B-MS acquires iPierian, a privately held biotechnology company focused on the discovery and development of new treatments for Tauopathies, for $175M.

An international team of pain researchers led by scientists at McGill University have found that the gender of the experimenters has a big impact on the stress levels of rodents.

The facility in Philadelphia is expected to become operational in the second quarter of 2015.

Scientists from the University of Manchester have discovered that microbes in smaller groups are more likely to mutate, resulting in higher rates of antibiotic resistance.

Researchers hope discovery will lead to improvements in drugs that act on the sodium channel to treat a range of cardiac and pain conditions.

The funding has been awarded to develop advanced imaging technologies, to maximise their potential to reduce animal use in a diverse range of preclinical research applications.

Appointment of Dr Peter Hunt represents part of further growth across all areas of its business.

Study gives researchers important clues to the genetic causes of particular kind of breast cancer.

Drug Shortages Prevention Plan for the pharmaceutical and biopharmaceutical industry.

Takeover extends Sartorius Stedim Biotech portfolio for single-use bioprocessing.